MusclePharm Corporation (OTCBB:MSLP), one of the fastest growing nutritional supplement companies in the United States, has been invited to present at the upcoming HIV DART(TM) 2010: Frontiers in Drug development for Antiretroviral Therapies Conference being held from December 7-10, 2010 in Los Cabos, Mexico.

This innovative conference, HIV DART(TM) 2010, will uniquely blend the areas of biology, chemistry, pharmacology and clinical research to provide the scientific community an increased understanding of the current and future challenges in therapeutics for HIV infection. This brings leaders in the research community together to advance the medical communities knowledge of the ongoing drug development processes in antiretroviral research.

At this year's HIV DART(TM) 2010 Conference, MusclePharm will present its results on the use of its product, Recon, in HIV patients. Early results show that Recon may help prevent the onset of wasting syndrome by facilitating the growth and maintenance of muscle mass in people living with HIV, which has been associated with antiretroviral drug resistance.

MusclePharm is currently striving to obtain Medicaid approval for the product in states with designated Eligible Metropolitan Areas under the Ryan White HIV/AIDS Treatment Modernization Act.

MusclePharm has recently expanded their market to include therapeutic medical modalities beginning with the utilization of Recon, a multi-component therapeutic nutritional supplement in the treatment of people living with HIV and AIDS.

**************************************

Haemonetics Corporation (NYSE:HAE) recently reported GAAP net revenues of $166.8 million, up 6%, net income of $21.3 million, up 18%, and earnings per share of $0.85, up 23%. Excluding transformation costs and contingent consideration income in fiscal 11, adjusted second quarter net income was $20.1 million, up 11%, and adjusted earnings per share was $0.80, up 16%. In constant currency, revenue was up 7%, adjusted net income was up 12% and adjusted earnings per share were up 16%.

Haemonetics Corporation provides blood management solutions primarily in the United States, Europe, and Asia.

**************************************

Macatawa Bank Corporation (NASDAQ:MCBC) recently announced its second consecutive quarter of profitability and improvements in several key capital and operational ratios in the third quarter 2010. Net income of $703,000, compared to a loss of $20.9 million in the same quarter of last year.

Macatawa Bank Corporation operates as the holding company for Macatawa Bank that provides various commercial and personal banking services.

**************************************

Family Dollar Stores, Inc. (NYSE:FDO) recently announced that technology solution provider, Direct Source, Inc., has been named IT Strategic Partner of the Year at the Company’s Annual IT Strategic Partner Summit. Joshua Jewett, Family Dollar Senior Vice President, Information Technology, CIO presented the award to representatives of Direct Source.

Headquartered in Minneapolis, Minn., Direct Source is a nationwide technology solutions provider for tier one retail, financial, and travel and lodging industries, with a network of more than 2,500 installation specialists.

**************************************************************

********************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOmega.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOmega.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyomega.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for 30 (thirty) days of advertising for MusclePharm Corporation (MSLP.OB)